Fused Deposition Modelling (FDM) in Personalized Medicine-An Overview on the Rise of Fused Deposition Model
DOI:
https://doi.org/10.37285/ijpsn.2023.16.2.8Abstract
Three-dimensional 3D printing is a trending technology that makes complex 3D bodies by settling materials layer by layer. 3D printing uses different materials. And to make this technique sustainable, research has been going on. FDM is one of the special 3d printing techniques that are more affordable than other techniques due to its ease of availability and affordability. FDM 3D printing is based on the melt extrusion of thermoplastic polymers for the creation of objects. It is an emerging technique for creating customized and complex dosage forms tailored to the needs of the patient. This customizability makes FDM a powerful method for fabricating personalized and patient-tailored dosage forms. Therefore, in the last few years research has increased in demonstrating the utilization of FDM to produce solid dosage forms. There are many research articles published in the last 7 years. This review gives a basic overview of FDM and several stages involved in FDM 3D printing, filament preparation from hot-melt extrusion, and various new applications.
Downloads
Metrics
Keywords:
Additive manufacturing, Clinical trials, Computer-aided drug design, Drug delivery, Fused deposition modeling, personalized medicine, Stereolithography, Selective laser sintering, 3D Printing technology
Downloads
Published
How to Cite
Issue
Section
References
Park BJ, Choi HJ, Moon SJ, Kim SJ, Bajracharya R, Min JY, et al. Pharmaceutical applications of 3D printing technology: current understanding and future perspectives. J Pharm Investig [Internet]. 2018 Oct 29 [cited 2022 Mar 14]; Available from: http://link.springer.com/10.1007/s40005-018-00414-y
Samiei N. Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: a mini review. Beni-Suef Univ J Basic Appl Sci. 2020 Dec;9(1):12.
Melnyk LA, Oyewumi MO. Integration of 3D printing technology in pharmaceutical compounding: Progress, prospects, and challenges. Ann 3D Print Med. 2021 Dec;4:100035.
Dumpa N, Butreddy A, Wang H, Komanduri N, Bandari S, Repka MA. 3D printing in personalized drug delivery: An overview of hot-melt extrusion-based fused deposition modeling. Int J Pharm. 2021 May;600:120501.
Vaz VM, Kumar L. 3D Printing as a Promising Tool in Personalized Medicine. AAPS PharmSciTech. 2021 Jan;22(1):49.
Araújo M, Sa-Barreto L, Gratieri T, Gelfuso G, Cunha-Filho M. The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality. Pharmaceutics. 2019 Mar 19;11(3):128.
Hsiao WK, Lorber B, Reitsamer H, Khinast J. 3D printing of oral drugs: a new reality or hype? Expert Opin Drug Deliv. 2018 Jan 2;15(1):1–4.
Mostafaei A, Elliott AM, Barnes JE, Li F, Tan W, Cramer CL, et al. Binder jet 3D printing—Process parameters, materials, properties, modeling, and challenges. Prog Mater Sci. 2021 Jun;119:100707.
Robles-Martinez P, Xu X, Trenfield SJ, Awad A, Goyanes A, Telford R, et al. 3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method. Pharmaceutics. 2019 Jun 11;11(6):274.
Wang Z, Han X, Chen R, Li J, Gao J, Zhang H, et al. Innovative color jet 3D printing of levetiracetam personalized paediatric preparations. Asian J Pharm Sci. 2021 May;16(3):374–86.
Scoutaris N, Ross SA, Douroumis D. 3D Printed “Starmix” Drug Loaded Dosage Forms for Paediatric Applications. Pharm Res. 2018 Feb;35(2):34.
Januskaite P, Xu X, Ranmal SR, Gaisford S, Basit AW, Tuleu C, et al. I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets. Pharmaceutics. 2020 Nov 17;12(11):1100.
Goyanes A, Madla CM, Umerji A, Duran Piñeiro G, Giraldez Montero JM, Lamas Diaz MJ, et al. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients. Int J Pharm. 2019 Aug;567:118497.
Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T. 3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets. Biol Pharm Bull. 2017;40(3):357–64.
Li R, Ting YH, Youssef S, Song Y, Garg S. Three-Dimensional Printing for Cancer Applications: Research Landscape and Technologies. Pharmaceuticals. 2021 Aug 10;14(8):787.
Shaqour B, Samaro A, Verleije B, Beyers K, Vervaet C, Cos P. Production of Drug Delivery Systems Using Fused Filament Fabrication: A Systematic Review. Pharmaceutics. 2020 Jun 5;12(6):517
Mwema FM, Akinlabi ET. Basics of Fused Deposition Modelling (FDM). In: Fused Deposition Modeling [Internet]. Cham: Springer International Publishing; 2020 [cited 2022 Mar 14]. p. 1–15. (SpringerBriefs in Applied Sciences and Technology). Available from: http://link.springer.com/10.1007/978-3-030-48259-6_1
Nasereddin J. An investigation into the feasibility of Fused Deposition Modelling for 3D printing oral pharmaceuticals. 2020 [cited 2022 Mar 14]; Available from:
http://rgdoi.net/10.13140/RG.2.2.18012.41603
Cailleaux S, Sanchez-Ballester NM, Gueche YA, Bataille B, Soulairol I. Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines. J Controlled Release. 2021 Feb;330:821–41.
Tan D, Maniruzzaman M, Nokhodchi A. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery. Pharmaceutics. 2018 Oct 24;10(4):203
Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T. 3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets. Biol Pharm Bull. 2017;40(3):357–64.
Goyanes A, Buanz ABM, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014 Dec;476(1–2):88–92.
Ibrahim M, Barnes M, McMillin R, Cook DW, Smith S, Halquist M, et al. 3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies. AAPS PharmSciTech. 2019 Jul;20(5):195.
Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci. 2015 Feb;68:11–7.
Goyanes A, Buanz ABM, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2015 Jan;89:157–62.
Beck RCR, Chaves PS, Goyanes A, Vukosavljevic B, Buanz A, Windbergs M, et al. 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems. Int J Pharm. 2017 Aug;528(1–2):268–79.
Maroni A, Melocchi A, Parietti F, Foppoli A, Zema L, Gazzaniga A. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J Controlled Release. 2017 Dec;268:10–8.
Krause J, Bogdahn M, Schneider F, Koziolek M, Weitschies W. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. Eur J Pharm Sci. 2019 Dec;140:105060.
Melocchi A, Uboldi M, Cerea M, Foppoli A, Maroni A, Moutaharrik S, et al. A Graphical Review on the Escalation of Fused Deposition Modeling (FDM) 3D Printing in the Pharmaceutical Field. J Pharm Sci. 2020 Oct;109(10):2943–57.
Shin S, Kim TH, Jeong SW, Chung SE, Lee DY, Kim DH, et al. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs. Uzun E, editor. PLOS ONE. 2019 May 15;14(5):e0216875.
Smith DM, Kapoor Y, Klinzing GR, Procopio AT. Pharmaceutical 3D printing: Design and qualification of a single step print and fill capsule. Int J Pharm. 2018 Jun;544(1):21–30.
Fu J, Yin H, Yu X, Xie C, Jiang H, Jin Y, et al. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. Int J Pharm. 2018 Oct;549(1–2):370–9.
Linares V, Casas M, Caraballo I. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery. Eur J Pharm Biopharm. 2019 Jan;134:138–43.
Zhang J, Feng X, Patil H, Tiwari RV, Repka MA. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm. 2017 Mar;519(1–2):186–97.
Palekar S, Nukala PK, Mishra SM, Kipping T, Patel K. Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen. Int J Pharm. 2019 Feb;556:106–16.
Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, et al. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm. 2015 Dec;496(2):414–20.
Fuenmayor E, Forde M, Healy A, Devine D, Lyons J, McConville C, et al. Material Considerations for Fused-Filament Fabrication of Solid Dosage Forms. Pharmaceutics. 2018 Apr 2;10(2):44.
Solanki NG, Tahsin M, Shah AV, Serajuddin ATM. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. J Pharm Sci. 2018 Jan;107(1):390–401.
Yang Y, Wang H, Li H, Ou Z, Yang G. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release. Eur J Pharm Sci. 2018 Mar;115:11–8.
Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema L. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int J Pharm. 2016 Jul;509(1–2):255–63.
Zhao J, Xu X, Wang M, Wang L. A New Model of a 3D-Printed Shell with Convex Drug Release Profile. Dissolution Technol. 2018;25(1):24–8.
Kadry H, Al-Hilal TA, Keshavarz A, Alam F, Xu C, Joy A, et al. Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption. Int J Pharm. 2018 Jun;544(1):285–96.
Yang Y, Wang H, Li H, Ou Z, Yang G. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release. Eur J Pharm Sci. 2018 Mar;115:11–8.
Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci. 2015 Feb;68:11–7.
Wald NJ. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003 Jun 26;326(7404):1419–0.
Gioumouxouzis CI, Baklavaridis A, Katsamenis OL, Markopoulou CK, Bouropoulos N, Tzetzis D, et al. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Eur J Pharm Sci. 2018 Jul;120:40–52.
Shin S, Kim TH, Jeong SW, Chung SE, Lee DY, Kim DH, et al. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs. Uzun E, editor. PLOS ONE. 2019 May 15;14(5):e0216875.
Chai X, Chai H, Wang X, Yang J, Li J, Zhao Y, et al. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone. Sci Rep. 2017 Dec;7(1):2829.
Huanbutta K, Sangnim T. Design and development of zero-order drug release gastroretentive floating tablets fabricated by 3D printing technology. J Drug Deliv Sci Technol. 2019 Aug;52:831–7.
Fu J, Yin H, Yu X, Xie C, Jiang H, Jin Y, et al. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. Int J Pharm. 2018 Oct;549(1–2):370–9.
Wu L, Park J, Kamaki Y, Kim B. Optimization of the fused deposition modeling-based fabrication process for polylactic acid microneedles. Microsyst Nanoeng. 2021 Dec;7(1):58.
Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges. Pharm Res. 2018 Sep;35(9):176.
Ehtezazi T, Algellay M, Islam Y, Roberts M, Dempster NM, Sarker SD. The Application of 3D Printing in the Formulation of Multilayered Fast Dissolving Oral Films. J Pharm Sci. 2018 Apr;107(4):1076–85.
